Scarica l'app Stockscreener
4.01
6.08%
0.23
Dopo l'orario di chiusura:
4.01
Precedente Chiudi:
$3.78
Aprire:
$3.74
Volume 24 ore:
1.51M
Relative Volume:
1.03
Capitalizzazione di mercato:
$398.30M
Reddito:
$58.36M
Utile/perdita netta:
$-25.72M
Rapporto P/E:
-11.01
EPS:
-0.3641
Flusso di cassa netto:
$-24.91M
1 W Prestazione:
+0.50%
1M Prestazione:
+0.00%
6M Prestazione:
+15.56%
1 anno Prestazione:
+2.30%
Intervallo 1D:
$3.73
$4.10
Intervallo di 1 settimana:
$3.6903
$4.27
Portata 52W:
$2.12
$5.80
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Nome
Aquestive Therapeutics Inc
Settore
Telefono
908-941-1900
Indirizzo
30 TECHNOLOGY DRIVE, WARREN, NJ
Confronta AQST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.01 | 383.41M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2024-12-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-28 | Iniziato | Raymond James | Outperform |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-04-22 | Iniziato | H.C. Wainwright | Buy |
| 2019-01-03 | Iniziato | Lake Street | Buy |
| 2018-08-20 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-08-20 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2025 Earnings Call Transcript - Insider Monkey
Aquestive Therapeutics Inc (AQST) Q2 2025 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada
Aquestive Therapeutics Inc. Rebound Backed by Sentiment ShiftJuly 2025 Intraday Action & High Accuracy Swing Trade Signals - 선데이타임즈
Aquestive Therapeutics Reports Q2 2025 Financial Results - TipRanks
Aquestive Therapeutics Q2 2025 Earnings: What to Expect - AInvest
Aquestive's Q2 2025 Earnings Call: Navigating Contradictions in FDA Approval, Launch Readiness, and Market Strategy - AInvest
Aquestive Therapeutics, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:AQST) - Seeking Alpha
Transcript : Aquestive Therapeutics, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Earnings call transcript: Aquestive Therapeutics Q2 2025 sees EPS beat, revenue miss - Investing.com UK
Aquestive Therapeutics Q2 2023 Earnings Report & AnalysisNews and Statistics - IndexBox
Aquestive 2025 Q2 Earnings Net Loss Widens Sharply - AInvest
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates - MSN
Compared to Estimates, Aquestive Therapeutics (AQST) Q2 Earnings: A Look at Key Metrics - Nasdaq
Aquestive Therapeutics: Q2 Earnings Snapshot - San Francisco Chronicle
Aquestive Therapeutics shares rise 2.33% after-hours after FDA accepts NDA submission for Anaphylm™. - AInvest
Aquestive Therapeutics: Positioning for a Game-Changing 2026 Launch of Anaphylm - AInvest
Aquestive Q2 2025 slides: Anaphylm advances toward FDA decision, cash burn continues By Investing.com - Investing.com South Africa
Aquestive Q2 2025 slides: Anaphylm advances toward FDA decision, cash burn continues - Investing.com
Aquestive Therapeutics earnings beat by $0.03, revenue fell short of estimates - Investing.com Canada
Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Aquestive Therapeutics Inc (AQST) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Aquestive Therapeutics Inc Q2 2025 Earnings Preview: Revenue Expectations Fall to $11.32M, Earnings at -$0.17 per Share - AInvest
Aquestive Therapeutics Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Uncovering Potential: Aquestive Therapeutics's Earnings Preview - 富途牛牛
Aquestive Therapeutics Inc (AQST) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
What caused AQST's surprising Q2 2024 EPS surge? - AInvest
Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET - The Manila Times
Aquestive Therapeutics Q2 2025 Earnings Release Date Set for August 11 | AQST Stock News - Stock Titan
Why is Aquestive Therapeutics Inc. stock attracting strong analyst attentionInvest confidently with real-time data analysis - Jammu Links News
What is the risk reward ratio of investing in Aquestive Therapeutics Inc. stockTrack top-performing stocks in real-time - Jammu Links News
What makes Aquestive Therapeutics Inc. stock price move sharplyAccelerated investment success - Jammu Links News
How does Aquestive Therapeutics Inc. compare to its industry peersCapitalize on market momentum for maximum gains - Jammu Links News
What institutional investors are buying Aquestive Therapeutics Inc. stockDiscover breakthrough investment opportunities - Jammu Links News
What drives Aquestive Therapeutics Inc. stock priceCapitalize on market momentum for maximum gains - Jammu Links News
What is the dividend policy of Aquestive Therapeutics Inc. stockInvest confidently with data-driven strategies - Jammu Links News
What analysts say about Aquestive Therapeutics Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
How strong is Aquestive Therapeutics Inc. company’s balance sheetExceptional market performance - Jammu Links News
What are the latest earnings results for Aquestive Therapeutics Inc.Unlock powerful stock screening tools today - Jammu Links News
What are Aquestive Therapeutics Inc. company’s key revenue driversCapitalize on emerging investment opportunities - Jammu Links News
What are the technical indicators suggesting about Aquestive Therapeutics Inc.Unlock powerful market trend analysis - Jammu Links News
Should I hold or sell Aquestive Therapeutics Inc. stock in 2025Significant capital appreciation - Jammu Links News
Aquestive Therapeutics Faces Regulatory Challenges with '5050Item' - AInvest
Is Aquestive Therapeutics Inc. stock overvalued or undervaluedPost Market Guidance For Smart Trading - Jammu Links News
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) 39% Share Price Surge Not Quite Adding Up - 富途牛牛
Aquestive Therapeutics Faces Potential Risks with ‘5050Item’: What Investors Need to Know - TipRanks
Investors Hope for Bounce in Aquestive Therapeutics Inc. After SelloffAI Based High Gain Watchlist Scanner Shared - beatles.ru
Strategies to average down on Aquestive Therapeutics Inc.Stock Selection With High Accuracy Based on Models - metal.it
Why Aquestive Therapeutics Inc. is moving todayReal-Time Trade Insights Spark Market Reactions - metal.it
Why Aquestive Therapeutics Inc. stock attracts strong analyst attentionAI Forecast Accuracy Evaluation Forecast - beatles.ru
Published on: 2025-07-29 20:47:23 - beatles.ru
Published on: 2025-07-29 19:03:19 - beatles.ru
Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):